| Serial Number | 79317018 |
| Word Mark | NEORNAT |
| Filing Date | Thursday, June 24, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 15, 2022 |
| Registration Number | 6897544 |
| Registration Date | Tuesday, November 15, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 30, 2022 |
| Description of Mark | The mark consists of the wording "NEORNAT" in indigo stylized font with the letter "E" formed by three horizontal indigo lines. |
| Goods and Services | Anti-cancer preparations; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; diagnostic agents for pharmaceutical use; drug delivery agents in the form of in the form of tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs, namely, pharmaceutical preparations for the treatment of cancer; medicines for human purposes for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for use in oncology; pharmaceuticals for the treatment of cancer; non-prescription medicines for the treatment of cancer; biological preparations for the treatment of cancer |
| Indication of Colors claimed | The color indigo is claimed as a feature of the mark. |
| Goods and Services | Scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; consultancy relating to research in the field of pharmacogenetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consulting services in the field of pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; medical laboratory services; medical research laboratory services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 6, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 6, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NEORNAT |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul KR |
| Party Name | NEORNAT |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul KR |
| Party Name | NEORNAT |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul KR |
| Event Date | Event Description |
| Wednesday, March 29, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, March 8, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, March 8, 2023 | FINAL DISPOSITION PROCESSED |
| Wednesday, February 15, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 15, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 15, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 30, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 30, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 10, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, July 27, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 27, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, July 27, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 27, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 27, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, July 22, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 22, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 22, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 20, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, July 20, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, July 20, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, July 20, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, July 20, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, July 20, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, May 24, 2022 | REFUSAL PROCESSED BY IB |
| Monday, May 16, 2022 | ATTORNEY REVIEW COMPLETED |
| Monday, May 16, 2022 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| Wednesday, May 4, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, May 4, 2022 | REFUSAL PROCESSED BY MPU |
| Saturday, April 9, 2022 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Wednesday, March 23, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, March 22, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 16, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, August 10, 2021 | APPLICATION FILING RECEIPT MAILED |
| Friday, August 6, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 5, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |